Brief: Bioporto To Redraw U.S. Application For Regulatory Clearance Of NGAL Test For Risk Assessment For AKI In Patients Under The Age Of 22

BioPorto A/S

13/07/2019 12:53

July 13 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO TO REDRAW U.S. APPLICATION FOR REGULATORY
CLEARANCE
OF THE NGAL TEST™ FOR RISK ASSESSMENT FOR AKI IN PATIENTS UNDER
THE AGE OF 22 WITH THE INTEND TO RESUBMIT IN Q4 2019
    * BIOPORTO - AS A CONSEQUENCE OF REDRAW, BIOPORTO SUSPENDS
ITS
FINANCIAL GUIDANCE FOR 2019 UNTIL PUBLICATION OF INTERIM REPORT
FOR FIRST HALF OF 2019

Source text for Eikon:  ID:nGNE1KZdKN 
Further company coverage:  BIOPOR.CO 

 ((Reuters.Briefs@thomsonreuters.com;))